EUGENIE LHOMMEE

(CHU Grenoble Alpes)

Corps & Espace

Coordonnées

Service de MPR - Neuro

CHU Grenoble-Alpes

Cs 10217, 38043 Grenoble cedex 9

Tél. +33 (0)4 76 76 60 60

Eugenie.Lhommee@univ-grenoble-alpes.fr

Troubles cognitifs et comportementaux dans la maladie de Parkinson de 2004 à 2023

Cognition spatiale dans l'AVC à partir de 2024

Disciplines scientifiques

Neuropsychologie

 
Long-term independence and quality of life after subthalamic stimulation in Parkinson disease.
Castrioto A, Debû B, Cousin E, Pelissier P, Lhommée E, Bichon A, Schmitt E, Kistner A, Meoni S, Seigneuret E, Chabardes S, Krack P, Moro E, Fraix V. Eur J Neurol. 2022 Sep;29(9):2645-2653. doi: 10.1111/ene.15436. Epub 2022 Jun 24. PMID: 35666167 Free PMC article.

Early Parkinson's Disease Phenotypes Tailored by Personality, Behavior, and Motor Symptoms.
Meira B, Lhommée E, Schmitt E, Klinger H, Bichon A, Pélissier P, Anheim M, Tranchant C, Fraix V, Meoni S, Durif F, Houeto JL, Azulay JP, Moro E, Thobois S, Krack P, Castrioto A; Honeymoon study group. J Parkinsons Dis. 2022;12(5):1665-1676. doi: 10.3233/JPD-213070. PMID: 35527563

Fatigue in de novo Parkinson's Disease: Expanding the Neuropsychiatric Triad?
Béreau M, Castrioto A, Lhommée E, Maillet A, Gérazime A, Bichon A, Pélissier P, Schmitt E, Klinger H, Longato N, Fraix V, Benatru I, Durif F, Azulay JP, Moro E, Broussolle E, Tranchant C, Anheim M, Thobois S, Krack P. J Parkinsons Dis. 2022;12(4):1329-1337. doi: 10.3233/JPD-213116. PMID: 35253781

Limbic Serotonergic Plasticity Contributes to the Compensation of Apathy in Early Parkinson's Disease.
Prange S, Metereau E, Maillet A, Klinger H, Schmitt E, Lhommée E, Bichon A, Lancelot S, Meoni S, Broussolle E, Castrioto A, Tremblay L, Krack P, Thobois S. Mov Disord. 2022 Jun;37(6):1211-1221. doi: 10.1002/mds.28971. Epub 2022 Mar 3. PMID: 35238430

Serotonergic and Dopaminergic Lesions Underlying Parkinsonian Neuropsychiatric Signs.
Maillet A, Météreau E, Tremblay L, Favre E, Klinger H, Lhommée E, Le Bars D, Castrioto A, Prange S, Sgambato V, Broussolle E, Krack P, Thobois S. Mov Disord. 2021 Dec;36(12):2888-2900. doi: 10.1002/mds.28722. Epub 2021 Sep 8. PMID: 34494685

Predictors of Long-Term Outcome of Subthalamic Stimulation in Parkinson Disease.
Cavallieri F, Fraix V, Bove F, Mulas D, Tondelli M, Castrioto A, Krack P, Meoni S, Schmitt E, Lhommée E, Bichon A, Pélissier P, Chevrier E, Kistner A, Seigneuret E, Chabardès S, Moro E. Ann Neurol. 2021 Mar;89(3):587-597. doi: 10.1002/ana.25994. Epub 2021 Jan 9. PMID: 33349939

A randomized controlled double-blind study of rotigotine on neuropsychiatric symptoms in de novo PD.
Castrioto A, Thobois S, Anheim M, Quesada JL, Lhommée E, Klinger H, Bichon A, Schmitt E, Durif F, Azulay JP, Houeto JL, Longato N, Philipps C, Pelissier P, Broussolle E, Moro E, Tranchant C, Fraix V, Krack P; Honeymoon study group. NPJ Parkinsons Dis. 2020 Dec 15;6(1):41. doi: 10.1038/s41531-020-00142-x. PMID: 33319786 Free PMC article.
Dopaminergic modulation of emotional conflict in Parkinson's disease.
Fleury V, Cousin E, Czernecki V, Schmitt E, Lhommée E, Poncet A, Fraix V, Troprès I, Pollak P, Krainik A, Krack P. Front Aging Neurosci. 2014 Jul 23;6:164. doi: 10.3389/fnagi.2014.00164. eCollection 2014. PMID: 25100991 Free PMC article.

Mechanisms of body weight fluctuations in Parkinson's disease.
Kistner A, Lhommée E, Krack P. Front Neurol. 2014 Jun 2;5:84. doi: 10.3389/fneur.2014.00084. eCollection 2014. PMID: 24917848 Free PMC article. Review.

Iowa gambling task impairment in Parkinson's disease can be normalised by reduction of dopaminergic medication after subthalamic stimulation.
Castrioto A, Funkiewiez A, Debû B, Cools R, Lhommée E, Ardouin C, Fraix V, Chabardès S, Robbins TW, Pollak P, Krack P. J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):186-90. doi: 10.1136/jnnp-2013-307146. Epub 2014 May 23. PMID: 24860137

Dopamine and the biology of creativity: lessons from Parkinson's disease.
Lhommée E, Batir A, Quesada JL, Ardouin C, Fraix V, Seigneuret E, Chabardès S, Benabid AL, Pollak P, Krack P. Front Neurol. 2014 Apr 22;5:55. doi: 10.3389/fneur.2014.00055. eCollection 2014. PMID: 24795692 Free PMC article.

Mood and behavioural effects of subthalamic stimulation in Parkinson's disease.
Castrioto A, Lhommée E, Moro E, Krack P. Lancet Neurol. 2014 Mar;13(3):287-305. doi: 10.1016/S1474-4422(13)70294-1. Epub 2014 Feb 17. PMID: 24556007 Review.

Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil.
Thobois S, Lhommée E, Klinger H, Ardouin C, Schmitt E, Bichon A, Kistner A, Castrioto A, Xie J, Fraix V, Pelissier P, Chabardes S, Mertens P, Quesada JL, Bosson JL, Pollak P, Broussolle E, Krack P. Brain. 2013 May;136(Pt 5):1568-77. doi: 10.1093/brain/awt067. Epub 2013 Mar 29. PMID: 23543483 Clinical Trial.

Levodopa-resistant freezing of gait and executive dysfunction in Parkinson's disease.
Ferraye MU, Ardouin C, Lhommée E, Fraix V, Krack P, Chabardès S, Seigneuret E, Benabid AL, Pollak P, Debû B. Eur Neurol. 2013;69(5):281-8. doi: 10.1159/000346432. Epub 2013 Feb 27. PMID: 23445615

Psychostimulant effect of levodopa: reversing sensitisation is possible.
Castrioto A, Kistner A, Klinger H, Lhommée E, Schmitt E, Fraix V, Chabardès S, Mertens P, Quesada JL, Broussolle E, Pollak P, Thobois SC, Krack P. J Neurol Neurosurg Psychiatry. 2013 Jan;84(1):18-22. doi: 10.1136/jnnp-2012-302444. Epub 2012 Sep 18. PMID: 22991345 Clinical Trial.

Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial.
Moreau C, Delval A, Defebvre L, Dujardin K, Duhamel A, Petyt G, Vuillaume I, Corvol JC, Brefel-Courbon C, Ory-Magne F, Guehl D, Eusebio A, Fraix V, Saulnier PJ, Lagha-Boukbiza O, Durif F, Faighel M, Giordana C, Drapier S, Maltête D, Tranchant C, Houeto JL, Debû B, Sablonniere B, Azulay JP, Tison F, Rascol O, Vidailhet M, Destée A, Bloem BR, Bordet R, Devos D; Parkgait-II study group. Lancet Neurol. 2012 Jul;11(7):589-96. doi: 10.1016/S1474-4422(12)70106-0. Epub 2012 Jun 1. PMID: 22658702 Clinical Trial.

Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.
Lhommée E, Klinger H, Thobois S, Schmitt E, Ardouin C, Bichon A, Kistner A, Fraix V, Xie J, Aya Kombo M, Chabardès S, Seigneuret E, Benabid AL, Mertens P, Polo G, Carnicella S, Quesada JL, Bosson JL, Broussolle E, Pollak P, Krack P. Brain. 2012 May;135(Pt 5):1463-77. doi: 10.1093/brain/aws078. Epub 2012 Apr 15. PMID: 22508959
[Behavioral disorders in Parkinson's disease: from pathophysiology to the mastery of dopaminergic treatment].
Thobois S, Ardouin C, Schmitt E, Lhommée E, Klinger H, Xie J, Lagrange C, Kistner A, Aya Kombo M, Fleury V, Poisson A, Fraix V, Broussolle E, Pollak P, Krack P. Rev Neurol (Paris). 2010 Oct;166(10):816-21. doi: 10.1016/j.neurol.2010.07.006. Epub 2010 Aug 23. PMID: 20739041 Review. French.

[Usefulness of repetitive transcranial magnetic stimulation in psychiatric disorders].
Szekely D, Polosan M, Grimaldi I, Buis C, Lhommée E, Bougerol T. Rev Med Interne. 2010 Jul;31(7):508-14. doi: 10.1016/j.revmed.2009.08.007. Epub 2010 Apr 14. PMID: 20395024 French.

Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
Thobois S, Ardouin C, Lhommée E, Klinger H, Lagrange C, Xie J, Fraix V, Coelho Braga MC, Hassani R, Kistner A, Juphard A, Seigneuret E, Chabardes S, Mertens P, Polo G, Reilhac A, Costes N, LeBars D, Savasta M, Tremblay L, Quesada JL, Bosson JL, Benabid AL, Broussolle E, Pollak P, Krack P. Brain. 2010 Apr;133(Pt 4):1111-27. doi: 10.1093/brain/awq032. Epub 2010 Mar 17. PMID: 20237128 Clinical Trial.

[Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease].
Ardouin C, Chéreau I, Llorca PM, Lhommée E, Durif F, Pollak P, Krack P; groupe évaluation comportementale de la maladie de Parkinson. Rev Neurol (Paris). 2009 Nov;165(11):845-56. doi: 10.1016/j.neurol.2009.06.003. Epub 2009 Aug 15. PMID: 19683776 Review. French.

Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation.
Ardouin C, Voon V, Worbe Y, Abouazar N, Czernecki V, Hosseini H, Pelissolo A, Moro E, Lhommée E, Lang AE, Agid Y, Benabid AL, Pollak P, Mallet L, Krack P. Mov Disord. 2006 Nov;21(11):1941-6. doi: 10.1002/mds.21098. PMID: 16972268 Clinical Trial.

Publié le 18 décembre 2024

Mis à jour le 18 décembre 2024